Toxic Oligomers of the Amyloidogenic HypF-N Protein Form Pores in Mitochondrial Membranes
Authors
Affiliations
Studies on the amyloidogenic N-terminal domain of the E. coli HypF protein (HypF-N) have contributed significantly to a detailed understanding of the pathogenic mechanisms in neurodegenerative diseases characterised by the formation of misfolded oligomers, by proteins such as amyloid-β, α-synuclein and tau. Given that both cell membranes and mitochondria are increasingly recognised as key targets of oligomer toxicity, we investigated the damaging effects of aggregates of HypF-N on mitochondrial membranes. Essentially, we found that HypF-N oligomers characterised by high surface hydrophobicity (type A) were able to trigger a robust permeabilisation of mito-mimetic liposomes possessing cardiolipin-rich membranes and dysfunction of isolated mitochondria, as demonstrated by a combination of mitochondrial shrinking, lowering of mitochondrial membrane potential and cytochrome c release. Furthermore, using single-channel electrophysiology recordings we obtained evidence that the type A aggregates induced currents reflecting formation of ion-conducting pores in mito-mimetic planar phospholipid bilayers, with multi-level conductances ranging in the hundreds of pS at negative membrane voltages. Conversely, HypF-N oligomers with low surface hydrophobicity (type B) could not permeabilise or porate mitochondrial membranes. These results suggest an inherent toxicity of membrane-active aggregates of amyloid-forming proteins to mitochondria, and that targeting of oligomer-mitochondrial membrane interactions might therefore afford protection against such damage.
, inflammation and prion protein binding.
Forloni G, La Vitola P, Balducci C Front Neurosci. 2022; 16:822420.
PMID: 36081661 PMC: 9445368. DOI: 10.3389/fnins.2022.822420.
Dynamics of Amyloid Formation from Simplified Representation to Atomistic Simulations.
Nguyen P, Tuffery P, Derreumaux P Methods Mol Biol. 2022; 2405:95-113.
PMID: 35298810 DOI: 10.1007/978-1-0716-1855-4_5.
Sharif N Front Pharmacol. 2021; 12:729249.
PMID: 34603044 PMC: 8484316. DOI: 10.3389/fphar.2021.729249.
Errico S, Ramshini H, Capitini C, Canale C, Spaziano M, Barbut D ACS Chem Neurosci. 2021; 12(17):3189-3202.
PMID: 34382791 PMC: 8414483. DOI: 10.1021/acschemneuro.1c00327.
Amyloid Prefibrillar Oligomers: The Surprising Commonalities in Their Structure and Activity.
Diociaiuti M, Bonanni R, Cariati I, Frank C, DArcangelo G Int J Mol Sci. 2021; 22(12).
PMID: 34208561 PMC: 8235680. DOI: 10.3390/ijms22126435.